Cargando…

注射用盐酸美法仑预处理自体造血干细胞移植治疗多发性骨髓瘤125例的疗效和安全性

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10033269/
https://www.ncbi.nlm.nih.gov/pubmed/36948870
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2023.02.011
_version_ 1784910975390973952
collection PubMed
description
format Online
Article
Text
id pubmed-10033269
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Editorial office of Chinese Journal of Hematology
record_format MEDLINE/PubMed
spelling pubmed-100332692023-03-24 注射用盐酸美法仑预处理自体造血干细胞移植治疗多发性骨髓瘤125例的疗效和安全性 Zhonghua Xue Ye Xue Za Zhi 短篇论著 Editorial office of Chinese Journal of Hematology 2023-02 /pmc/articles/PMC10033269/ /pubmed/36948870 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2023.02.011 Text en 2023年版权归中华医学会所有 https://creativecommons.org/licenses/by/3.0/This work is licensed under a Creative Commons Attribution 3.0 License.
spellingShingle 短篇论著
注射用盐酸美法仑预处理自体造血干细胞移植治疗多发性骨髓瘤125例的疗效和安全性
title 注射用盐酸美法仑预处理自体造血干细胞移植治疗多发性骨髓瘤125例的疗效和安全性
title_full 注射用盐酸美法仑预处理自体造血干细胞移植治疗多发性骨髓瘤125例的疗效和安全性
title_fullStr 注射用盐酸美法仑预处理自体造血干细胞移植治疗多发性骨髓瘤125例的疗效和安全性
title_full_unstemmed 注射用盐酸美法仑预处理自体造血干细胞移植治疗多发性骨髓瘤125例的疗效和安全性
title_short 注射用盐酸美法仑预处理自体造血干细胞移植治疗多发性骨髓瘤125例的疗效和安全性
title_sort 注射用盐酸美法仑预处理自体造血干细胞移植治疗多发性骨髓瘤125例的疗效和安全性
topic 短篇论著
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10033269/
https://www.ncbi.nlm.nih.gov/pubmed/36948870
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2023.02.011
work_keys_str_mv AT zhùshèyòngyánsuānměifǎlúnyùchùlǐzìtǐzàoxuègànxìbāoyízhízhìliáoduōfāxìnggǔsuǐliú125lìdeliáoxiàohéānquánxìng
AT zhùshèyòngyánsuānměifǎlúnyùchùlǐzìtǐzàoxuègànxìbāoyízhízhìliáoduōfāxìnggǔsuǐliú125lìdeliáoxiàohéānquánxìng
AT zhùshèyòngyánsuānměifǎlúnyùchùlǐzìtǐzàoxuègànxìbāoyízhízhìliáoduōfāxìnggǔsuǐliú125lìdeliáoxiàohéānquánxìng
AT zhùshèyòngyánsuānměifǎlúnyùchùlǐzìtǐzàoxuègànxìbāoyízhízhìliáoduōfāxìnggǔsuǐliú125lìdeliáoxiàohéānquánxìng
AT zhùshèyòngyánsuānměifǎlúnyùchùlǐzìtǐzàoxuègànxìbāoyízhízhìliáoduōfāxìnggǔsuǐliú125lìdeliáoxiàohéānquánxìng
AT zhùshèyòngyánsuānměifǎlúnyùchùlǐzìtǐzàoxuègànxìbāoyízhízhìliáoduōfāxìnggǔsuǐliú125lìdeliáoxiàohéānquánxìng
AT zhùshèyòngyánsuānměifǎlúnyùchùlǐzìtǐzàoxuègànxìbāoyízhízhìliáoduōfāxìnggǔsuǐliú125lìdeliáoxiàohéānquánxìng
AT zhùshèyòngyánsuānměifǎlúnyùchùlǐzìtǐzàoxuègànxìbāoyízhízhìliáoduōfāxìnggǔsuǐliú125lìdeliáoxiàohéānquánxìng
AT zhùshèyòngyánsuānměifǎlúnyùchùlǐzìtǐzàoxuègànxìbāoyízhízhìliáoduōfāxìnggǔsuǐliú125lìdeliáoxiàohéānquánxìng
AT zhùshèyòngyánsuānměifǎlúnyùchùlǐzìtǐzàoxuègànxìbāoyízhízhìliáoduōfāxìnggǔsuǐliú125lìdeliáoxiàohéānquánxìng
AT zhùshèyòngyánsuānměifǎlúnyùchùlǐzìtǐzàoxuègànxìbāoyízhízhìliáoduōfāxìnggǔsuǐliú125lìdeliáoxiàohéānquánxìng
AT zhùshèyòngyánsuānměifǎlúnyùchùlǐzìtǐzàoxuègànxìbāoyízhízhìliáoduōfāxìnggǔsuǐliú125lìdeliáoxiàohéānquánxìng
AT zhùshèyòngyánsuānměifǎlúnyùchùlǐzìtǐzàoxuègànxìbāoyízhízhìliáoduōfāxìnggǔsuǐliú125lìdeliáoxiàohéānquánxìng
AT zhùshèyòngyánsuānměifǎlúnyùchùlǐzìtǐzàoxuègànxìbāoyízhízhìliáoduōfāxìnggǔsuǐliú125lìdeliáoxiàohéānquánxìng